Compare CCEL & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCEL | POCI |
|---|---|---|
| Founded | 1989 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 34.7M |
| IPO Year | 2022 | 2008 |
| Metric | CCEL | POCI |
|---|---|---|
| Price | $3.01 | $4.29 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.7K | ★ 16.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.82% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $25,384,279.00 | $19,091,269.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.76 | N/A |
| 52 Week Low | $3.10 | $3.77 |
| 52 Week High | $6.79 | $6.04 |
| Indicator | CCEL | POCI |
|---|---|---|
| Relative Strength Index (RSI) | 18.18 | 42.72 |
| Support Level | N/A | $4.03 |
| Resistance Level | $3.57 | $4.85 |
| Average True Range (ATR) | 0.06 | 0.33 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 1.89 | 31.77 |
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.